MNOV
MEDICINOVA INC
NASDAQ · Healthcare · Biotechnology · US
$1.42
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 17.69x
- P/S forward
- 96.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.88x
- Price / sales
- 75.93x
- Price / cash flow
- -0.04x
Enterprise value
- Enterprise value
- $44.6M
- EV / sales
- 48.45x
- EV / EBITDA
- -4.07x
- EV / EBIT
- -3.76x
- Market cap
- $69.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026